| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3988364 | European Journal of Surgical Oncology (EJSO) | 2008 | 6 Pages |
Abstract
In HCC patients, high peripheral and portal HGF serum levels related with poor prognosis after hepatic resection. Hepatocyte growth factor and c-met receptor can be targets of future HCC postoperative treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
G.-Y. Chau, W.-Y. Lui, C.-W. Chi, Y.-P. Chau, A.-F. Li, H.-L. Kao, C.-W. Wu,